New Key Statistics Module, Z-Score and F-Score
NAS:ETON Key Ratios
Market Cap $ M | 91.59 |
Enterprise Value $ M | 80.59 |
P/E(ttm) | 89.13 |
PE Ratio without NRI | 89.13 |
Forward PE Ratio | 14.27 |
Price/Book | 5.94 |
Price/Sales | 2.72 |
Price/Free Cash Flow | 23.62 |
Price/Owner Earnings | 133.87 |
Payout Ratio % | -- |
Revenue (TTM) $ M | 34.00 |
EPS (TTM) $ | 0.04 |
Beneish M-Score | -2.84 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 60.40 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | 148.70 |
EV-to-EBITDA | 54.38 |
PEG | 1.48 |
Shares Outstanding M | 25.69 |
Net Margin (%) | 2.66 |
Operating Margin % | 1.58 |
Pre-tax Margin (%) | 3.38 |
Quick Ratio | 1.43 |
Current Ratio | 1.59 |
ROA % (ttm) | 3.07 |
ROE % (ttm) | 6.02 |
ROIC % (ttm) | 5.33 |
Dividend Yield % | -- |
Altman Z-Score | 0.50 |
ETON Number of Guru Trades
ETON Volume of Guru Trades
Gurus Latest Trades with NAS:ETON
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:ETON is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Eton Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:ETON
Total 0- 1